Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beam Therapeutics (BEAM) Amortizatization of Intangibles (2019 - 2025)

Beam Therapeutics (BEAM) has disclosed Amortizatization of Intangibles for 7 consecutive years, with $3.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Amortizatization of Intangibles fell 29.78% to $3.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $16.0 million, a 29.9% decrease, with the full-year FY2025 number at $16.0 million, down 29.9% from a year prior.
  • Amortizatization of Intangibles was $3.3 million for Q4 2025 at Beam Therapeutics, down from $4.2 million in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $7.9 million in Q3 2023 to a low of -$15000.0 in Q1 2021.
  • A 5-year average of $3.9 million and a median of $4.4 million in 2025 define the central range for Amortizatization of Intangibles.
  • Peak YoY movement for Amortizatization of Intangibles: plummeted 111.63% in 2021, then skyrocketed 12768.0% in 2022.
  • Beam Therapeutics' Amortizatization of Intangibles stood at $47000.0 in 2021, then soared by 10755.32% to $5.1 million in 2022, then soared by 44.14% to $7.4 million in 2023, then plummeted by 36.91% to $4.6 million in 2024, then fell by 29.78% to $3.3 million in 2025.
  • Per Business Quant, the three most recent readings for BEAM's Amortizatization of Intangibles are $3.3 million (Q4 2025), $4.2 million (Q3 2025), and $4.6 million (Q2 2025).